FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2778326867> ?p ?o ?g. }

• W2778326867 endingPage "1038" @default.
• W2778326867 startingPage "1029" @default.
• W2778326867 abstract "Nuclear factor kappa B (NF-κB) plays an important role in the epithelial-mesenchymal transition (EMT) of RPE cells. We investigated the effects of a proteasome inhibitor, bortezomib, on the EMT in RPE cells. In addition, we assessed the influence of bortezomib on regulation of the NF-κB pathway during this process.After treatment with various concentrations of bortezomib, cell viability was analyzed with the water-soluble tetrazolium salt-8 assay, cell-cycle regulation was evaluated with flow cytometry, and cell migration was monitored with in vitro wound healing and Transwell migration assays. To induce fibroblastoid transformation, the RPE cells were treated with recombinant human transforming growth factor (TGF)-β1 (10 ng/ml), and western blot and immunocytochemical analyses were performed to evaluate altered expression of EMT markers after treatment with bortezomib. To verify the effect of bortezomib on shrinkage by myofibroblastic transformation, a contraction assay of the RPE-collagen gel lattice was performed.Treatment with bortezomib decreased RPE viability in a dose-dependent manner, and flow cytometry revealed that these effects were due to arrest of the G2/M phase cell-cycle. In the in vitro wound healing and Transwell migration assays, treatment with 20 nM bortezomib significantly impeded RPE migration. Treatment with bortezomib also significantly inhibited TGF-β1-induced transdifferentiation of the RPE cells. The effects on proliferation, migration, and the EMT were mediated by regulation of the NF-κB signaling pathway. In addition, bortezomib inhibited contraction of the RPE-collagen gel lattices.Bortezomib inhibits myofibroblastic transformation of RPE cells by downregulating NF-κB expression and prevents contraction of the RPE-collagen gel matrix. Thus, bortezomib represents a candidate putative therapeutic agent for management of retinal fibrotic diseases." @default.
• W2778326867 created "2018-01-05" @default.
• W2778326867 creator A5002774151 @default.
• W2778326867 creator A5017446883 @default.
• W2778326867 creator A5017569678 @default.
• W2778326867 creator A5017935217 @default.
• W2778326867 creator A5020502619 @default.
• W2778326867 creator A5051060008 @default.
• W2778326867 creator A5057016744 @default.
• W2778326867 creator A5091615384 @default.
• W2778326867 date "2017-01-01" @default.
• W2778326867 modified "2023-10-17" @default.
• W2778326867 title "Bortezomib inhibits proliferation, migration, and TGF-β1-induced epithelial-mesenchymal transition of RPE cells." @default.
• W2778326867 cites W118980975 @default.
• W2778326867 cites W1597783107 @default.
• W2778326867 cites W1818209566 @default.
• W2778326867 cites W1964094843 @default.
• W2778326867 cites W1971835444 @default.
• W2778326867 cites W1973638003 @default.
• W2778326867 cites W1976207005 @default.
• W2778326867 cites W2002006291 @default.
• W2778326867 cites W2002174302 @default.
• W2778326867 cites W2005025375 @default.
• W2778326867 cites W2012770017 @default.
• W2778326867 cites W2029020203 @default.
• W2778326867 cites W2035263256 @default.
• W2778326867 cites W2035654152 @default.
• W2778326867 cites W2041403839 @default.
• W2778326867 cites W2049716874 @default.
• W2778326867 cites W2059443125 @default.
• W2778326867 cites W2061061470 @default.
• W2778326867 cites W2061548364 @default.
• W2778326867 cites W2067192388 @default.
• W2778326867 cites W2067313207 @default.
• W2778326867 cites W2071989867 @default.
• W2778326867 cites W2074789428 @default.
• W2778326867 cites W2088631757 @default.
• W2778326867 cites W2092509198 @default.
• W2778326867 cites W2099257830 @default.
• W2778326867 cites W2111274886 @default.
• W2778326867 cites W2125480368 @default.
• W2778326867 cites W2138102966 @default.
• W2778326867 cites W2141290206 @default.
• W2778326867 cites W2142641037 @default.
• W2778326867 cites W2151892297 @default.
• W2778326867 cites W2151948287 @default.
• W2778326867 cites W2162248918 @default.
• W2778326867 cites W2188118051 @default.
• W2778326867 cites W2222298775 @default.
• W2778326867 cites W2238159161 @default.
• W2778326867 cites W2313829999 @default.
• W2778326867 cites W2320174469 @default.
• W2778326867 cites W2513515127 @default.
• W2778326867 cites W2612630749 @default.
• W2778326867 cites W70021726 @default.
• W2778326867 cites W74427414 @default.
• W2778326867 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5757857" @default.
• W2778326867 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29386876" @default.
• W2778326867 hasPublicationYear "2017" @default.
• W2778326867 type Work @default.
• W2778326867 sameAs 2778326867 @default.
• W2778326867 citedByCount "5" @default.
• W2778326867 countsByYear W27783268672020 @default.
• W2778326867 countsByYear W27783268672022 @default.
• W2778326867 countsByYear W27783268672023 @default.
• W2778326867 crossrefType "journal-article" @default.
• W2778326867 hasAuthorship W2778326867A5002774151 @default.
• W2778326867 hasAuthorship W2778326867A5017446883 @default.
• W2778326867 hasAuthorship W2778326867A5017569678 @default.
• W2778326867 hasAuthorship W2778326867A5017935217 @default.
• W2778326867 hasAuthorship W2778326867A5020502619 @default.
• W2778326867 hasAuthorship W2778326867A5051060008 @default.
• W2778326867 hasAuthorship W2778326867A5057016744 @default.
• W2778326867 hasAuthorship W2778326867A5091615384 @default.
• W2778326867 hasConcept C104317684 @default.
• W2778326867 hasConcept C127561419 @default.
• W2778326867 hasConcept C137738243 @default.
• W2778326867 hasConcept C1491633281 @default.
• W2778326867 hasConcept C153911025 @default.
• W2778326867 hasConcept C185592680 @default.
• W2778326867 hasConcept C198826908 @default.
• W2778326867 hasConcept C203014093 @default.
• W2778326867 hasConcept C27740335 @default.
• W2778326867 hasConcept C2776364478 @default.
• W2778326867 hasConcept C2777478702 @default.
• W2778326867 hasConcept C2778367456 @default.
• W2778326867 hasConcept C29537977 @default.
• W2778326867 hasConcept C502942594 @default.
• W2778326867 hasConcept C53227056 @default.
• W2778326867 hasConcept C553184892 @default.
• W2778326867 hasConcept C55493867 @default.
• W2778326867 hasConcept C62112901 @default.
• W2778326867 hasConcept C76419328 @default.
• W2778326867 hasConcept C86803240 @default.
• W2778326867 hasConcept C95444343 @default.
• W2778326867 hasConceptScore W2778326867C104317684 @default.
• W2778326867 hasConceptScore W2778326867C127561419 @default.
• W2778326867 hasConceptScore W2778326867C137738243 @default.

• next